Sesen Bio Inc.

Sesen Bio, Inc. engages in designing, engineering, and developing targeted protein therapeutics. It offers Vicineum and Proxinium, which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Carisma Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of immunotherapies. It offers chimeric antigen receptor (CAR)-macrophages, a cell therapy platform focusing on the treatment of solid tumors. The company was founded by Michael Klichinsky and Saar Gill in April 2016 and is headquartered in Philadelphia, PA.

Mind Medicine MindMed

PharmaCyte Biotech

Several penny stocks out there have done very well recently but these three biotechs are waiting for positive FDA news to soar higher. The post 3 Penny Stocks Waiting on FDA Approval for Rocket Fuel appeared first on InvestorPlace.

3 Penny Stocks Waiting on FDA Approval for Rocket Fuel

New York, New York--(Newsfile Corp. - October 18, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Sesen Bio, Inc. (NASDAQ: SESN) ("Sesen Bio") between December 21, 2020 and August 17, 2021. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Southern District of New York. To get more information...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Sesen Bio, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 18, 2021 - SESN

AppHarvest

HyreCar

NEW YORK, NY / ACCESSWIRE / October 17, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment.

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of SESN, HYRE and APPH

Hyzon Motors

NEW YORK, NY / ACCESSWIRE / October 15, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court.

LAWSUITS FILED AGAINST SESN, HYRE and HYZN - Jakubowitz Law Pursues Shareholders Claims

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Sesen To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - October 15, 2021) -  Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Sesen Bio, Inc. ("Sesen" or the "Company") (NASDAQ: SESN) and reminds investors of the October 18, 2021 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. If you suffered losses exceeding $100,000 investing in Sesen stock or options...

Sesen Update

View

NEW YORK, NY / ACCESSWIRE / October 15, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit.

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of VIEW, SESN and APPH

LOS ANGELES--(BUSINESS WIRE)---- $SESN #investors--The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Sesen Bio, Inc. (SESN)

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Sesen Bio, Inc. (SESN)

Endo International

Kosmos Energy

OncoSec Medical

Waitr Holdings Inc

5 Penny Stocks To Buy According To Analysts The post 5 Top Penny Stocks Analysts Say To Buy With 119%-430% Price Targets appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

5 Top Penny Stocks Analysts Say To Buy With 119%-430% Price Targets

San Diego, California--(Newsfile Corp. - October 14, 2021) - Robbins Geller Rudman & Dowd LLP announces that purchasers of Sesen Bio, Inc. (NASDAQ: SESN) securities between December 21, 2020 and August 17, 2021, both dates inclusive (the "Class Period"), have until this upcoming Monday, October 18, 2021, to seek appointment as lead plaintiff in Bibb v. Sesen Bio, Inc., No. 21-cv-07025, the Sesen Bio class action lawsuit. The Sesen Bio class action lawsuit...

FINAL SESN DEADLINE: Sesen, Bio, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Boston Beer Company

Cassava Sciences Inc

NEW YORK, NY / ACCESSWIRE / October 14, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment.

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of SESN, SAVA and SAM

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Sesen To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - October 14, 2021) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Sesen Bio, Inc. ("Sesen" or the "Company") (NASDAQ: SESN) and reminds investors of the October 18, 2021 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. If you suffered losses exceeding $100,000 investing in Sesen stock or...

Sesen Class Action Reminder

Los Angeles, California--(Newsfile Corp. - October 14, 2021) -  The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Sesen Bio, Inc. ("Sesen Bio" or "the Company") (NASDAQ: SESN) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company's securities between December 21, 2020 and August 17, 2021,...

DEADLINE MONDAY REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Sesen Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

BENSALEM, Pa., Oct. 14, 2021 /PRNewswire/ -- Law Offices of Howard G.

SESN Investors Have Opportunity to Lead Sesen Bio, Inc. Securities Fraud Lawsuit

NEW YORK--(BUSINESS WIRE)--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Sesen Bio, Inc. ("Sesen Bio" or the "Company") (NASDAQ: SESN) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Sesen Bio securities between December 21, 2020 and August 17, 2021, inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm's site: www.bgandg.com/sesn. This class a

SESN Upcoming Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Sesen Bio, Inc. Investors With Losses Exceeding $400K of Class Action and Lead Plaintiff Deadline: October 18, 2021

The stock price of Sesen Bio Inc (NASDAQ: SESN) increased by over 26% today. This is why it happened.

SESN Stock: Why It Substantially Increased Today

NEW YORK, NY / ACCESSWIRE / October 13, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court.

CLASS ACTION UPDATE for VIEW, SESN and SAM: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

New York, New York--(Newsfile Corp. - October 13, 2021) - The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders of Sesen Bio, Inc. (NASDAQ: SESN).Shareholders who purchased shares of SESN during the class period listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.CONTACT US HERE: https://securitiesclasslaw.com/securities/sesen-bio-inc-loss-submission-form/?id=20410&from=5

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Sesen Bio, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 18, 2021 - (SESN)

New York, New York--(Newsfile Corp. - October 13, 2021) -  Bernstein Liebhard LLP announces that a securities class action lawsuit has been filed on behalf of those who purchased or acquired the securities of Sesen Bio, Inc. (NASDAQ: SESN) between December 21, 2020 and August 17, 2021. The lawsuit seeks to recover Sesen Bio, Inc. shareholders' investment losses. The lawsuit filed in the United States District Court for the Southern District of New York alleges...

SESEN BIO, INC. (SESN) SHAREHOLDER LAWSUIT OCTOBER 18, 2021 FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Sesen Bio, Inc.

ATI Physical Therapy

Nano-X Imaging

NEW YORK, NY / ACCESSWIRE / October 13, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment.

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ATIP, SESN and NNOX

New York, New York--(Newsfile Corp. - October 13, 2021) - The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on behalf of investors who purchased Sesen Bio, Inc. (NASDAQ: SESN) ("Sesen Bio") between December 21, 2020 and August 17, 2021.If you suffered a loss, contact us at the link below. There is no cost or obligation to you.https://www.wongesq.com/pslra-1/sesen-bio-inc-loss-submission-form?prid=20386&wire=5

SESN LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Sesen Bio, Inc.

New York, New York--(Newsfile Corp. - October 13, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Sesen Bio, Inc. (NASDAQ: SESN) alleging that the Company violated federal securities laws.Class Period: December 21, 2020 and August 17, 2021Lead Plaintiff Deadline: October 18, 2021No obligation or cost to you.Learn more about your recoverable losses in SESN:https://www.kleinstocklaw.com/pslra-1/sesen-bio-inc-loss-submission-form?id=20377&from=5

SESN ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of October 18, 2021 in the Class Action Filed on Behalf of Sesen Bio, Inc. Limited Shareholders

NEW YORK, NY / ACCESSWIRE / October 12, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court.

Lawsuits Filed Against ATIP, SESN and APPH - Jakubowitz Law Pursues Shareholders Claims

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Sesen To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - October 12, 2021) -  Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Sesen Bio, Inc. ("Sesen" or the "Company") (NASDAQ: SESN) and reminds investors of the October 18, 2021 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. If you suffered losses exceeding $100,000 investing in Sesen stock or options...

Sesen Shareholder Alert

Agile Therapeutics

Kintara Therapeutics

Progenity

Looking for biotech penny stocks to watch on Reddit? Check these four out for your list The post Best Biotech Penny Stocks on Reddit to Buy Now?

Best Biotech Penny Stocks on Reddit to Buy Now? 4 For Your Watchlist

Los Angeles, California--(Newsfile Corp. - October 12, 2021) -  The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Sesen Bio, Inc. ("Sesen Bio" or "the Company") (NASDAQ: SESN) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company's securities between December 21, 2020 and August 17, 2021,...

MONDAY DEADLINE REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Sesen Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

News for Sesen Bio Inc. Stock (SESN)